EMA Mapping RWD Landscape To Bridge Evidence Gap For Duchenne Drugs

 
• By Vibha Sharma
  
Tablet with diagnosis muscular dystrophy and stethoscope.
EU Study will identify DMD data sources and their regulatory value (Shutterstock)

More from Real-World Evidence

More from Clinical Trials